INTELLIGENCE IN ACTION

HIMSS17: Combating the Opioid Epidemic

February 08, 2017

Our nation has been crippled by the devastating opioid addiction epidemic. According to the Centers for Disease Control, opioid drug overdoses played a role in 33,091 deaths in the United States in 2015, and that number is expected to continue to rise.

To address this growing public health crisis, healthcare industry experts must work together to develop innovative and effective solutions. Electronic prescribing of controlled substances (EPCS) is one weapon providers can use to help curb fraud and abuse. Digitizing the prescribing process makes it easier for patients to get the chronic pain treatments they need, while making it harder for people to divert and illegally distribute prescription drugs. Providers are beginning to realize the power of EPCS, as evident in Surescripts’ 2015 National Progress Report. According to the report, EPCS increased by 667 percent in 2015 and the number of providers with EPCS technology increased by 359 percent.

Surescripts will host a panel discussion at HIMSS17 to explore how actionable intelligence, including access to medication history data, can help address the opioid crisis. The “Combating the Opioid Epidemic” panel will take place on Monday, February 20 at 3:45 p.m. EST at Surescripts booth #6660. I am excited to be the moderator of the panel and look forward to exploring how information access, data sharing and new technology can help address fraud and abuse. The panel will feature perspectives from care providers and technology developers who are taking action, including:

For more information on HIMSS17 and our presence at the event, visit himssconference.org and check out the Surescripts blog. Be sure to follow the conversation on Twitter via the @Surescripts handle and #HIMSS17 hashtag.

Combatting the Opioid Epidemic

Related Articles

November 11, 2019

50 Days and Counting: Take These Necessary Steps to Meet EPCS Requirements

Fraud and abuse are prevalent in the world of prescription painkillers. In 2017, a total of 61,311 people died from drug overdoses – with an estimated 40% from prescription opioid medicine. This is 61,311 too many. Opioid diversion is a significant cause of opioid misuse, with between 3% and 9% of diverted drugs tied to fraud or forgery of paper prescriptions.

Read more...
October 22, 2019

Now Trending: EPCS Among Physicians and Medicare Part D Patients

As we approach the one-year anniversary of the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities (SUPPORT) Act, I am optimistic about the direction of a key provision outlined in the legislation, that is, the use of electronic prescribing of controlled substance (EPCS) among Medicare Part D providers.  Read more...
July 30, 2019

Lessons Learned: How Connecticut Implemented an EPCS Requirement That Was Effective and Embraced by the Medical Community

Connecticut’s Electronic Prescribing of Controlled Substances (EPCS) requirement came into effect in January 2018. As Drug Control Director, I often serve as an advisor to state legislators who want to ensure the bills they draft are effective once they become law, so I was very active in the 2017 legislative session. While crafting this bill, we looked at how other states managed implementation of EPCS and worked closely with medical professionals to ensure that our legislation was thoughtful. We knew we had to consider the day-to-day operations of regulators and medical professionals, and ultimately what was best for patients.

Read more...

INTELLIGENCE IN ACTION, DELIVERED TO YOUR INBOX